Bartlomiej Piechowski-Jozwiak at ARDD2025: IHLAD and the Longevity Medicine Landscape

Value of the Information & Strength of the Argument

The talk provides valuable insights into the practical implementation of longevity medicine in a specific geographic and cultural context. The speaker presents concrete data from a survey on genetic knowledge and attitudes, which is useful for understanding public perceptions. The argumentation is based on the speaker’s experience and institutional initiatives, but it is largely descriptive and lacks critical analysis. The speaker does not address potential limitations of the survey or the challenges of implementing such programs. The value lies in the overview of ongoing projects and the emphasis on integrating research with clinical practice.

Scientific Rigor, Source Quality, Title Accuracy

The talk is an expert opinion, not a peer-reviewed presentation. The speaker cites the Emirati Genome Program and other government initiatives, but does not provide specific references or data sources. The title accurately reflects the content, as the talk focuses on IHLAD and the longevity medicine landscape. The speaker mentions unpublished data and ongoing projects, which limits the verifiability of the information. No comments were provided for analysis.

The title accurately reflects the content: the speaker presents IHLAD's role and the longevity medicine landscape in Abu Dhabi.

7/10

The talk is an expert opinion from a neurologist and head of research at IHLAD, presenting institutional initiatives and preliminary survey data. It is not peer-reviewed, but the speaker has relevant expertise and the data is from a real survey. The presentation is transparent about unpublished data and ongoing projects.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 02:00Introduction: speaker introduces himself and his background in neurology and stroke prevention.
• 05:00Health challenges in the UAE: high diabetes rates, obesity, and cardiovascular disease.
• 08:00Government strategic priorities: Emirati Genome Program, IFHAS screening, and digital health.
• 11:00IHLAD's role and achievements: licensing, research projects, and partnerships.
• 15:00Survey on genetic knowledge and attitudes: preliminary results and implications.
• 18:00Ongoing projects: culinary medicine and IRAS intervention.
• 21:00Innovation hub: advanced diagnostics, multi-omics, and AI capabilities.
• 24:00Conclusion: invitation for collaboration and summary of key points.

• Emirati Genome Program — Mentioned as a national initiative to sequence one million citizens.
• IFHAS (Integrated Health Assessment System) — Mentioned as a statewide screening program for adults.
• Malafi (Electronic Health Record) — Mentioned as the state-level EHR system.

• Emirati Genome Program — Official website of the Emirati Genome Program.
• Department of Health Abu Dhabi — Government health authority mentioned in the talk.